Clinical trial
A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to…
NCT00340184 · Korean Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00340184 |
|---|---|
| Title | A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients |
| Official title | A Phase II Trial of Radiation Therapy With Concurrent Paclitaxel/Carboplatin Chemotherapy in High-risk Cervical Cancer Patients After Radical Hysterectomy |
| Lead sponsor | Korean Gynecologic Oncology Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel, carboplatin |
| Enrollment | 55 |
| Start date | Aug 1, 2004 |
| First posted | Jun 21, 2006 |
| Last update posted | Oct 19, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: